100% cell death in prostate cancer!!Pharmagap's Holy Grail, GAP-107B8, is now the envy of the biopharmaceutical world :) Big Pharma will be eager to sign up to fund human trials now. And with NCI supporting data, and the efficacy and safety data coming from Sloan-Kettering in NY and Queen's University, Pharmagap will get Fast-Track status soon. A few more material NR to come in the next few weeks, or days ;) Spread the good word :D
DYODD and GLTAL